Status:
TERMINATED
DEPORRA-CoProst: Assessment of New Fluorescence Imagery Techniques Using Prostate Chips From Transurethral Resections
Lead Sponsor:
University Hospital, Grenoble
Collaborating Sponsors:
Laboratoire TIMC-IMAG
FEMTO-ST Institute
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The aim of this study is divided in 4 different steps: * the first step has two different purpose: assess the impact of the storage medium of fresh prostatic chips on fluorescence signal and adjust t...
Eligibility Criteria
Inclusion
- Male patient over 18 years old.
- Patient scheduled for trans-urethral resection of prostate with:
- prostate specific antigen (PSA) blood level ≤ 4 ng/ml and age \> 80 years old
- a suspected prostate cancer after a digital rectal examination (DRE) and a PSA blood level \> 50 ng/ml or an existing prostate cancer
- Patient affiliated to social security or beneficiary of such a regime.
Exclusion
- Protected patient referred to in Articles L1121-6 to L1121-8 of the Code of Public Health
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2015
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT02185170
Start Date
July 1 2014
End Date
September 1 2015
Last Update
September 22 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Grenoble University Hospital, Urology and Anatomopathology Department
Grenoble, France, 38043